Drug Type Small molecule drug |
Synonyms Ibuprofen L-lysine (JAN), Ibuprofen lysine (USAN), Solufenum + [5] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (12 Aug 2003), |
RegulationOrphan Drug (United States) |
Molecular FormulaC19H32N2O4 |
InChIKeyIHHXIUAEPKVVII-ZSCHJXSPSA-N |
CAS Registry57469-77-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06606 | Ibuprofen Lysine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ductus Arteriosus, Patent | United States | 13 Apr 2006 | |
Arthritis | Australia | 12 Aug 2003 | |
Back Pain | Australia | 12 Aug 2003 | |
Dysmenorrhea | Australia | 12 Aug 2003 | |
Headache | Australia | 12 Aug 2003 | |
Migraine Disorders | Australia | 12 Aug 2003 | |
Musculoskeletal Pain | Australia | 12 Aug 2003 | |
Tension-Type Headache | Australia | 12 Aug 2003 | |
Toothache | Australia | 12 Aug 2003 |
Phase 1 | - | 32 | orhftyuakf(bkfruagufh) = tqychzyswh fjgewasevr (wwqwqhlzer ) | - | 01 Aug 2018 | ||
Ibuprofen liquid capsule | orhftyuakf(bkfruagufh) = umbcloeagy fjgewasevr (wwqwqhlzer ) |